Updated Dec. 13, 2023 9:53 am ET
Pfizer shares tumbled Wednesday morning after the company said revenue could fall next year and issued 2024 guidance below analyst expectations.
Shares of the New York drugmaker fell by more than 8% in premarket trading.
Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8